Literature DB >> 12077491

Comparison of dialysis and clinical characteristics of patients with frequent and occasional hemodialysis-associated hypotension.

András Tislér1, Katalin Akócsi, Ibolya Hárshegyi, Gábor Varga, Sándor Ferenczi, Mária Grosz, Imre Kulcsár, Lajos Löcsey, József Sámik, István Solt, János Szegedi, Eszter Tóth, Gyula Wágner, István Kiss.   

Abstract

BACKGROUND: Symptomatic dialysis hypotension (DH) continues to be a common problem. By comparing patients prone and resistant to DH, several dialysis session and patient related characteristics have been identified that confer susceptibility to DH. Less is known, however, about the comparison of patients with frequent and only occasional DH. The aim of the study was to compare clinical and dialysis-session- (complicated by hypotension) related data between those with frequent (fDH) and those with occasional dialysis hypotension (oDH).
METHODS: Nine hundred and fifty-eight patients at 11 dialysis units were followed for 10 months and characteristics of patients with fDH (> or = 10 hypotensive events necessitating medical intervention) (n = 96) were compared to that of patients with oDH (1 or 2 events/10 months) (n = 130). Significant and independent predictors of fDH were obtained by multivariate logistic regression.
RESULTS: Significant differences between fDH vs. oDH patients were older age (64.4 vs. 56.9 years, p < 0.001), more females (66 vs. 46%, p < 0.005) in fDH. More fDH patients had diabetes (27 vs. 15%, p < 0.05) and less had glomerulonephritis (15 vs. 35%, p < 0.001) as the cause for ESRD. Coronary artery disease (68 vs. 50%, p < 0.01) and long-acting nitrate treatment (51 vs. 30%, p < 0.001) was more frequent while treatment with ACEI (33 vs. 48%, p < 0.05) or Ca-channel blockers (40 vs. 53%, p < 0.05) were less frequent in patients with fDH. Patients with fDH had higher serum phosphorus levels (1.99 vs. 1.79 mmol, p < 0.005). Dialysis session related data were similar but the hypotensive episode occurred earlier during dialysis in fDH (136 vs. 156 min, p < 0.01). In multivariate analysis, significant independent predictors of fDH were older age (OR = 1.04 [1.02-1.07]), lack of glomerulonephritis as renal diagnosis (2.63 [1.18-5.87]), high phosphorus levels (5.0 [2.45-10.0]), lack of use of Ca-channel blockers (2.09 [1.12-3.91]), and the use of nitrates (2.38 [1.24-4.55]).
CONCLUSION: Features of the dialysis sessions complicated by DH seem to be similar between patients with fDH and oDH, while patient characteristics such as older age, renal diagnosis other than glomerulonephritis, higher serum phosphorus levels, use of nitrates, and lack of use of calcium channel blockers are significantly and independently associated with fDH. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12077491     DOI: 10.1159/000063515

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  12 in total

Review 1.  Intradialytic Hypotension: Mechanisms and Outcome.

Authors:  Benedict Sars; Frank M van der Sande; Jeroen P Kooman
Journal:  Blood Purif       Date:  2019-12-18       Impact factor: 2.614

2.  Associations of endothelial dysfunction and arterial stiffness with intradialytic hypotension and hypertension.

Authors:  Ruth Dubin; Christopher Owens; Warren Gasper; Peter Ganz; Kirsten Johansen
Journal:  Hemodial Int       Date:  2011-06-09       Impact factor: 1.812

3.  Intradialytic hypotension and vascular access thrombosis.

Authors:  Tara I Chang; Jane Paik; Tom Greene; Manisha Desai; Fritz Bech; Alfred K Cheung; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2011-08       Impact factor: 10.121

Review 4.  Systolic blood pressure and mortality in patients on hemodialysis.

Authors:  Tara I Chang
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

Review 5.  Impact of drugs on intradialytic hypotension: Antihypertensives and vasoconstrictors.

Authors:  Tara I Chang
Journal:  Semin Dial       Date:  2017-07-05       Impact factor: 3.455

6.  Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis: A Cluster Randomized Trial.

Authors:  Tara I Chang; Emily Tamar Tatoian; Maria E Montez-Rath; Glenn M Chertow
Journal:  Kidney360       Date:  2021-09-16

7.  Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Authors:  Christian Daugaard Peters; Krista Dybtved Kjaergaard; Jens Dam Jensen; Kent Lodberg Christensen; Charlotte Strandhave; Ida Noerager Tietze; Marija Kristina Novosel; Bo Martin Bibby; Bente Jespersen
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

8.  Study protocol for a single-blind, placebo-controlled randomised trial of Tianjiu effects in patients with intradialytic hypotension.

Authors:  Ming-Yen Tsai; Yu-Jen Su; Hwee-Yeong Ng; Shih-Yu Chen; Yu-Chuen Huang; Chien-Hsing Wu; Yung-Hsiang Chen
Journal:  BMJ Open       Date:  2016-03-10       Impact factor: 2.692

9.  Prevalence of intradialytic hypotension, clinical symptoms and nursing interventions--a three-months, prospective study of 3818 haemodialysis sessions.

Authors:  Johanna Kuipers; Jurjen K Oosterhuis; Wim P Krijnen; Judith J Dasselaar; Carlo A J M Gaillard; Ralf Westerhuis; Casper F M Franssen
Journal:  BMC Nephrol       Date:  2016-02-27       Impact factor: 2.388

10.  A randomized controlled trial of long term effect of BCM guided fluid management in MHD patients (BOCOMO study): rationales and study design.

Authors:  Li Liu; Gang Long; Jianwei Ren; Jijun Li; Jinsheng Xu; Jinghong Lei; Mao Li; Moyan Qiu; Ping Yuan; Weiming Sun; Shan Lin; Wenjun Liu; Yi Sun; Yingchun Ma; Yonghui Mao; Yulan Shen; Li Zuo
Journal:  BMC Nephrol       Date:  2012-09-25       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.